ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1983

Mutations Associated with Clonal Hematopoiesis of Indeterminate Potential Are Found in Peripheral Blood and Synovial Fluid Macrophages from Patients with Rheumatoid and Psoriatic Arthritis

Maria De Santis1, Matteo Zampini2, Natasa Isailovic1, Elena Generali1, Giacomo Maria Guidelli1, Matteo Della Porta2 and Carlo Selmi1,3, 1Rheumatology and Clinical Immunology Unit, Humanitas Research Hospital, Rozzano (MI), Italy, 2Oncology and Hematology Unit, Humanitas Research Hospital, Humanitas University, Rozzano (MI), Italy, 3BIOMETRA Department, University of Milan, Milan, Italy

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Osteoarthritis, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Tuesday, October 23, 2018

Session Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Myeloidmutations commonly associated to neoplasia in patients who do not meet the diagnostic criteria for myelodysplastic syndrome are coined as clonal hematopoiesis of indeterminate potential (CHIP). CHIP-related mutations are somatic DNA mutations accumulating with aging, being found in approximately 10% of over 65. Chronic inflammation, mirrored by TNF-aexposure, has been reported to favor the expansion of CHIP-mutant clones, such as TET2- and JAK2-, but recent evidence suggests that CHIP-mutated clones contribute to chronic inflammation, as TET2-mutated myeloid clones manifest a hyper-inflammatory M1 status. We hypothesize that chronic inflammation concurs with age to CHIP-mutation appearance, i.e. they should be more precocious and frequent in rheumatic patients; moreover, CHIP-mutations are associated to more active rheumatic diseases.

Methods: We investigated the peripheral blood and synovial fluid myeloid cells from 4 rheumatoid arthritis (RA), 4 psoriatic arthritis (PsA), and 4 knee osteoarthritis (OA) patients (female 5, median age 73,5 years, range 53-91, median disease duration 10 years, range 7-20). To detect the presence of CHIP-mutations we used a high-throughput sequencing platform (Illumina NextSeq platform) for mutation screening of 78 genes known to be relevant in myelodysplastic diseases. We evaluated only variants known as pathogenic in COSMIC database, with a population frequency (MAF) < 0.1% described in dbSNP and in 1000 Genome Project.

Results: We found somatic mutations of JAK2, TP53, and TET2in 2/4 RA patients, GATA2-mutation in 1/4 PsA patients, and a small clone of SF3B1 in 1/4 OA cases. Mutated clones were found both in peripheral blood and synovial fluid of the patients. The patients with CHIP-mutations did not have a more active disease (DAS28-CRP 4.2±0.6 vs 5.1±1.2; p>0.05), but 1 RA patient with JAK2-mutation and 1 PsA patient had < 65years.

Conclusion: Our data suggests that CHIP-mutations are frequent in patients with chronic arthritis, also before 65 years. Understanding the mechanisms connecting somatic mutation-driven clonal hematopoiesis and chronic inflammation will be of great interest not only from a pathogenic point of view, but also in considering possible therapeutic options, such as JAK-inhibitors.


Disclosure: M. De Santis, None; M. Zampini, None; N. Isailovic, None; E. Generali, None; G. M. Guidelli, None; M. Della Porta, None; C. Selmi, AbbVie, Janssen, MSD, Novartis, Pfizer, 2,AbbVie, Alfa-Sigma, Biogen, Bristol-Myrs Squibb, Celgene, Eli-Lilly, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, Novartis, Pfizer, Roche, Sanofi-Genzyme, UCB, 5, 8.

To cite this abstract in AMA style:

De Santis M, Zampini M, Isailovic N, Generali E, Guidelli GM, Della Porta M, Selmi C. Mutations Associated with Clonal Hematopoiesis of Indeterminate Potential Are Found in Peripheral Blood and Synovial Fluid Macrophages from Patients with Rheumatoid and Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/mutations-associated-with-clonal-hematopoiesis-of-indeterminate-potential-are-found-in-peripheral-blood-and-synovial-fluid-macrophages-from-patients-with-rheumatoid-and-psoriatic-arthritis/. Accessed December 15, 2019.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mutations-associated-with-clonal-hematopoiesis-of-indeterminate-potential-are-found-in-peripheral-blood-and-synovial-fluid-macrophages-from-patients-with-rheumatoid-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.